Preferences help
enabled [disable] Abstract
Number of results
2008 | 55 | 2 | 297-305
Article title

Specific inhibition of procollagen C-endopeptidase activity by synthetic peptide with conservative sequence found in chordin

Title variants
Languages of publication
Procollagen C-endopeptidase (BMP-1) and N-endopeptidase (ADAMTS-2) are key enzymes for correct and efficient conversion of fibrillar procollagens to their self assembling monomers. Thus, they have an essential role in building and controlling the quality of extracellular matrices (ECMs). Here, we tested inhibition of activity of the largest variant of BMP-1, a recombinant mammalian tolloid (mTld), in vitro by three synthetic peptides with conservative amino-acid sequences found in chordin using procollagen type I as a substrate. We also verified the specific action of best inhibitory 16 amino-acid peptide in the procollagen type I cleavage assay with the use of ADAMTS-2 (procollagen N-endopeptidase). Subsequently, we determined the critical residues and minimal sequence of six amino acids in the original 16 amino-acid peptide required to maintain the inhibitory potential. Studies on the interactions of 6 and 16 amino acid long peptides with the enzyme revealed their binding to non-catalytic, regulatory domains of mTld; the inhibitory activity was not due to the competition of peptides with the substrate for the enzyme active center, because mTld did not cleave the peptides. However, in the presence of mTld both peptides underwent cyclization by disulfide bond formation. Concluding, we have shown that procollagen C-endopeptidase may be specifically blocked via its non-catalytic domains by synthetic peptide consisting of 6 amino acids in the sequence found in highly conservative region of chordin. Thus, we hypothesize that the 6 amino-acid peptide could be a good candidate for anti-fibrotic drug development.
Physical description
  • Department of General and Molecular Biology and Genetics, Center of Excellence for Research and Teaching of Molecular Biology of Matrix and Nanotechnology, Silesian Medical University in Katowice, Katowice, Poland
  • Department of General and Molecular Biology and Genetics, Center of Excellence for Research and Teaching of Molecular Biology of Matrix and Nanotechnology, Silesian Medical University in Katowice, Katowice, Poland
  • Department of General and Molecular Biology and Genetics, Center of Excellence for Research and Teaching of Molecular Biology of Matrix and Nanotechnology, Silesian Medical University in Katowice, Katowice, Poland
  • Department of General and Molecular Biology and Genetics, Center of Excellence for Research and Teaching of Molecular Biology of Matrix and Nanotechnology, Silesian Medical University in Katowice, Katowice, Poland
  • Department of General and Molecular Biology and Genetics, Center of Excellence for Research and Teaching of Molecular Biology of Matrix and Nanotechnology, Silesian Medical University in Katowice, Katowice, Poland
  • Amano S, Scott IC, Takahara K, Koch M, Champliaud MF, Gerecke DR, Keene DR, Hudson DL, Nishiyama T, Lee S, Greenspan DS, Burgeson RE (2000) Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 γ2 chain. J Biol Chem 275: 22728-22735.
  • Arnold WV, Sieron AL, Fertala A, Bachinger HP, Mechling D, Prockop DJ (1997) A cDNA cassette system for the synthesis of recombinant procollagens. Variants of procollagen II lacking a D-period are secreted as triple-helical monomers. Matrix Biol 16: 105-116.
  • Arnold WV, Fertala A, Sieron AL, Hattori H, Mechling D, Bachinger HP, Prockop DJ (1998) Recombinant procollagen II: Deletion of D period segments identifies sequences that are required for helix stabilization and generates a temperature-sensitive N-proteinase cleavage site. J Biol Chem 273: 31822-31828.
  • Blader P, Rastegar S, Fisher N, Strähle U (1997) Cleavage of the BMP-4 antagonist Chordin by zebrafish Tolloid. Science 278: 1937-1940.
  • Bugge TH, Flick MJ, Danton MJ, Daugherty CC, Romer J, Dano K, Carmeliet P, Collen D, Degen JL (1996a) Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc Natl Acad Sci USA 93: 5899-5904.
  • Bugge TH, Kombrinck KW, Flick MJ, Daugherty CC, Danton MJ, Degen JL (1996b) Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 87: 709-719.
  • Byth HA, Mchunu BI, Dubery IA, Bornman L (2001) Assessment of a simple, non-toxic Alamar blue cell survival assay to monitor tomato cell viability. Phytochem Anal 12: 340-346.
  • Celik I, Surucu O, Dietz C, Heymach JV, Force J, Hoschele I, Becker CM, Folkman J, Kisker O (2005) Therapeutic efficacy of endostatin exhibits a biphasic dose-response curve. Cancer Res 65: 11044-11050.
  • Colige A, Li SW, Sieron AL, Nusgens BV,Prockop DJ, Lapiere CM (1997) cDNA cloning and expression of bovine procollagen I N-proteinase: a new member of the superfamily of zinc-metalloproteinases with binding sites for cells and other matrix components. Proc Natl Acad Sci USA 94: 2374-2379.
  • Cronshaw AD, Fothergill-Gilmore LA, Hulmes DJS (1995) The proteolytic processing site of the precursor of lysyl oxidase. Biochem J 306: 279-284.
  • Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039.
  • Fertala A, Sieron AL, Ganguly A, Li SW, Ala-Kokko L, Anumula KR, Prockop DJ (1994) Synthesis of recombinant human procollagen II in a stably transfected tumour cell line (HT1080). Biochem J 298: 31-37.
  • Folkman J, D'Amore PA (1996) Blood vessel formation: what is its molecular basis? Cell 87: 1153-1155.
  • Gailit J, Clark RA (1994) Wound repair in the context of extracellular matrix. Curr Opin Cell Biol 6: 717-725.
  • Garrigue-Antar L, Francois V, Kalder KE (2004) Deletion of epidermal growth factor-like domains converts mammalian tolloid into a chordinase and effective procollagen C-proteinase. J Biol Chem 279: 49835-49841.
  • Ge G, Greenspan DS (2006) BMP1 controls TGFβ1 activation via cleavage of latent TGFβ-binding protein. J Cell Biol 175: 111-120
  • Ge G, Seo NS, Liang X, Hopkins DR, Höök M, Greenspan DS (2004) Bone morphogenetic protein-1/Tolloid-related metalloproteinases process osteoglycin and enhance its ability to regulate collagen fibrillogenesis. J Biol Chem 279: 41626-41633.
  • Grams F, Dive V, Yiotakis A, Yiallouros I, Vassiliou S, Zwilling R, Bode W, Stocker W (1996) Structure of astacin with a transition-state analogue inhibitor. Nat Struct Biol 3: 671-675.
  • Hartigan N, Garrigue-Antar L, Kadler KE (2003) Bone morphogenetic protein (BMP)-1: identification of the minimal domain structure for C-proteinase activity. J Biol Chem 278: 18045-18049.
  • Hojima Y, van der Rest M, Prockop DJ (1985) Type I procollagen carboxylterminal proteinase from chick embryo tendons. J Biol Chem 260: 15996-16003.
  • Hojima Y, McKenzie JA, van der Rest M, Prockop DJ (1989) Type I procollagen N-proteinase from chick embryo tendons. Purification of a new 500-kDa form of the enzyme and identification of the catalytically active polypeptides. J Biol Chem 264: 11336-11345.
  • Hojima Y, Behta B, Romanic AM, Prockop DJ (1994) Cleavage of type I procollagen by C- and N-proteinases is more rapid if the substrate is aggregated with dextran sulfate or polyethylene glycol. Anal Biochem 223: 173-180.
  • Huh JI, Calvo A, Stafford J, Cheung M, Kumar R, Philp D, Kleinman HK, Green JE (2005) Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and nonantiangiogenic mechanisms. Oncogene 24: 790-800.
  • Imamura Y, Steiglitz BM, Greenspan DS (1998) Bone morphogenetic protein-1 processes the NH_2-terminal propeptide, and a furin-like proprotein convertase processes the COOH-terminal propeptide of pro-α1(V) collagen. J Biol Chem 273: 27511-27517.
  • Kessler E, Takahara K, Biniaminov L, Brusel M, Greenspan DS (1996) Bone morphogenetic protein-1: the type I procollagen C-proteinase [see comments]. Science 271: 360-362.
  • Lapiere CM, Lenaers A, Kohn LD (1971) Procollagen peptidase: an enzyme excising the coordination peptides of procollagen. Proc Natl Acad Sci USA 68: 3054-3058.
  • Leung MK, Fessler LI, Greenberg DB, Fessler JH (1979) Separate amino and carboxyl procollagen peptidases in chick embryo tendon. J Biol Chem 254: 224-232.
  • Li SW, Sieron AL, Fertala A, Hojima Y, Arnold WV, Prockop DJ (1996) The C-proteinase that processes procollagens to collagens is identical to the protein previously identified as bone morphogenic protein-1. Proc Natl Acad Sci USA 93: 5127-5130.
  • Li SW, Arita M, Fertala A, Bao Y, Kopen GC, Langsjo TK, Hyttinen MM, Helminen HJ, Prockop DJ (2001) Transgenic mice with inactive alleles for procollagen N-proteinase (ADAMTS-2) develop fragile skin and male sterility. Biochem J 355: 271-278.
  • Marques G, Musacchio M, Simell MJ, Wunnenberg-Stapleton K, Cho KWY, O'Connor M (1997) Production of a DPP activity gradient in the early Drosophila embryo through the opposing actions of the SOG and TLD proteins. Cell 91: 417-426.
  • Montesano R, Pepper MS, Mohle-Steinlein U, Risau W, Wagner EF, Orci L (1990) Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell 62: 435-445.
  • Panchenko MV, Stelter-Stevenson WG, Trupetskoy OV, Gacheru SN, Kagan HM (1996) Metalloproteinase activity secreted by fibrogenic cells in the processing of prolysyl oxidase. Potential role of procollagen C-proteinase. J Biol Chem 271: 7113-7119.
  • Piccolo S, Agius E, Lu B, Goodman S, Dale L, De Robertis EM (1997) Cleavage of Chordin by Xolloid metalloprotease suggests a role for proteolytic processing in the regulation of Spemann organizer activity. Cell 91: 407-416.
  • Prockop DJ, Kivirikko KI (1984) Heritable diseases of collagen. N Engl J Med 311: 376-386.
  • Prockop DJ, Kivirikko KI, Tuderman L, Guzman NA (1979) Biosynthesis of collagen. N Engl J Med 301: 13-23.
  • Prockop DJ, Kivirikko KI, Tuderman L, Guzman NA (1979) Biosynthesis of collagen. N Engl J Med 301: 77-85.
  • Rattenholl A, Pappano WN, Koch M, Keene DR, Kadler KE, Sasaki T, Timpl R, Burgeson RE, Greenspan DS, Bruckner-Tuderman L (2002) Proteinases of the bone morphogenetic protein-1 family convert procollagen VII to mature anchoring fibril collagen. J Biol Chem 277: 26372-26378.
  • Risau W (1997) Mechanisms of angiogenesis. Nature 386: 671-674.
  • Scott IC, Imamura Y, Pappano WN, Troedel JM, Recklies AD, Roughley PJ, Greenspan DS (2000) Bone morphogenetic protein-1 processes probiglycan. J Biol Chem 275: 30504-30511.
  • Senger DR (1996) Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines. Am J Pathol 149: 1-7.
  • Sieron AL, Fertala A, Ala-Kokko L, Prockop DJ (1993) Deletion of a large domain in recombinant human procollagen II does not alter the thermal stability of the triple helix. J Biol Chem 268: 21232-21237.
  • Sieron AL, Tretiakova A, Jameson BA, Segall ML, Lund-Katz S, Khan MT, Li SW, Stöcker W (2000) Structure and function of procollagen C-proteinase (mTolloid) domains determined by protease digestion, circular dichroism, binding to procollagen type I, and computer modeling. Biochemistry 39: 3231-3239.
  • Steiglitz BM, Ayala M, Narayanan K, George A, Greenspan DS (2004) Bone morphogenetic protein-1/tolloid-like proteinases process dentin matrix protein-1. J Biol Chem 279: 980-986.
  • Sun J, Wang DA, Jain RK, Carie A, Paquette S, Ennis E, Blaskovich MA, Baldini L, Coppola D, Hamilton AD, Sebti SM (2005) Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors. Oncogene 24: 4701-4709.
  • Suzuki N, Labosky PA, Furuta Y, Hargett L, Dunn R, Fogo AB, Takahara K, Peters DM, Greenspan DS, Hogan BL (1996) Failure of ventral body wall closure in mouse embryos lacking a procollagen C-proteinase encoded by BMP-1, a mammalian gene related to Drosophila tolloid. Development 122: 3587-3595.
  • Takahara K, Lyons GE, Greenspan DS (1994) Bone morphogenetic protein-1 and a mammalian toloid homologue (mTld) are encoded by alternatively spliced transcripts which are differentially expressed in some tissues. J Biol Chem 269: 32572-32578.
  • Wolfman NM, McPherron AC, Pappano WN, Davies MV, Song K, Tomkinson KN, Wright JF, Zhao L, Sebald SM, Greenspan DS, Lee SJ (2003) Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Proc Natl Acad Sci USA 100: 15842-15846.
  • Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA (1988) Novel regulators of bone formation: Molecular clones and activities. Science 242: 1528-1534.
  • Wu Z, O'Reilly MS, Folkman J, Shing Y (1997) Suppression of tumor growth with recombinant murine angiostatin. Biochem Biophys Res Commun 236: 651-654.
  • Zhang T, Xu Q, Chen FR, Han QD, Zhang YY (2004) Yeast two-hybrid screening for proteins that interact with α1-adrenergic receptors. Acta Pharmacol Sin 25: 1471-1478.
  • Zhang Y, Ge G, Greenspan DS (2006) Inhibition of bone morphogenetic protein 1 by native and altered forms of α_2-macroglobulin. J Biol Chem 281: 39096-39104.
  • Zeng Q, Li S, Chepeha DB, Giordano TJ, Li J, Zhang H, Polverini PJ, Nor J, Kitajewski J, Wang CY (2005) Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer Cell 8: 13-23.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.